This paper presents a personal perspective on efforts during the past 15 years to replace animal testing for assessing the safety of chemicals and products. It is based on an invited lecture — the FRAME Annual Lecture — given in October 2005, with the theme of “making progress by working together” (government–industry–academia–NGOs). Where we have achieved some successes, these have clearly been due to effective cooperation and collaboration between the relevant stakeholders. In recent times, there has not been this same level of active commitment and coordination. This needs to change, since, if we are to make good progress in the years to come in responding to the new challenges of the EU policy to replace animal testing, this will undoubtedly require us to work together, hopefully facilitated by effective leadership and coordination from the EU policy-makers themselves.
EC (1986). Council Directive of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official Journal of the European CommunitiesL358, 1–29.
EC (1993). Council Directive 93/35/EEC of 14 June 1993 amending for the sixth time Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products. Official Journal of the European CommunitiesL151, 32–37.
5.
EU (2003). Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products. Official Journal of the European UnionL66, 26–35.
AtkinsonK.A., FentemJ.H., ClothierR.H., & BallsM. (1992). Alternatives to ocular irritation testing in animals. Lens & Eye Toxicity Research9, 247–258.
9.
BothamP.A., EarlL.K., FentemJ.H., RoguetR., & van de SandtJ.J.M. (1998). Alternative methods for skin irritation testing: the current status. ECVAM Skin Irritation Task Force Report 1. ATLA26, 195–211.
10.
BallsM., BlaauboerB., BrusickD., FrazierJ., LambD., PembertonM., ReinhardtC., RoberfroidM., RosenkranzH., SchmidB., SpielmannH., StammatiA-L., & WalumE. (1990). Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures. ATLA18, 339–344.
11.
GoldbergA.M., FrazierJ.M., BrusickD., DickensM.S., FlintO., GettingsS.D., HillR.N., LipnickR.L., RenskersK.J., BradlawJ.A., ScalaR.A., VeronesiB., GreenS., WilcoxN.L., & CurrenR.D. (1993). Framework for validation and implementation of in vitro toxicity tests: report of the Validation and Technology Transfer Committee of the Johns Hopkins Center for Alternatives to Animal Testing. Journal of the American College of Toxicologists12, 23–30.
12.
BasketterD.A., WhittleE., & ChamberlainM. (1994). Identification of irritation and corrosion hazards to skin: an alternative strategy to animal testing. Food & Chemical Toxicology32, 539–542.
13.
BallsM., BothamP.A., BrunerL.H., & SpielmannH. (1995). The EC/HO international validation study on alternatives to the Draize eye irritation test. Toxicology in Vitro9, 871–929.
14.
BallsM., BlaauboerB.J., FentemJ.H., BrunerL., CombesR.D., EkwallB., FielderR.J., GuillouzoA., LewisR.W., LovellD., ReinhardtC.A., RepettoG., SladowskiD., SpielmannH., & ZuccoF. (1995). Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop 5. ATLA23, 129–147.
15.
FentemJ.H., ArcherG.E.B., BallsM., BothamP.A., CurrenR.D., EarlL.K., EsdaileD.J., HolzhütterH.G., & LiebschM. (1998). The ECVAM international validation study on in vitro tests for skin corrosivity. 2. Results and evaluation by the Management Team. Toxicology in Vitro12, 483–524.
16.
SpielmannH., BallsM., DupuisJ., PapeW.J.W., PechovitchG., de SilvaO., HolzhütterH.G., ClothierR., DesolleP., GerberickF., LiebschM., LovellW.W., MaurerT., PfannenbeckerU., PotthastJ.M., CsatoM., SladowskiD., SteilingW., & BrantomP. (1998). EU/COLIPA “In vitro phototoxicity” validation study, results of phase II (blind trial), part 1: the 3T3 NRU phototoxicity test. Toxicology in Vitro12, 305–327.
17.
BallsM., De KlerckW., BakerF., van BeekM., BouillonC., BrunerL., CarstensenJ., ChamberlainM., CottinM., CurrenR., DupuisJ., FairweatherF., FaureU., FentemJ., FisherC., GalliC., KemperF., KnaapA., LangleyG., LoprienoG., LoprienoN., PapeW., PechovitchG., SpielmannH., UngarK., WhiteI., & ZuangV. (1995). Development and validation of non-animal tests and testing strategies: the identification of a coordinated response to the challenge and the opportunity presented by the Sixth Amendment to the Cosmetics Directive (76/768/EEC). The report and recommendations of an ECVAM/CPS workshop (ECVAM Workshop 7). ATLA23, 398–409.
18.
BallsM., GoldbergA.M., FentemJ.H., BroadheadC.L., BurchR.L., FestingM.F.W., FrazierJ.M., HendriksenC.F.M., JenningsM., van der KampM.D.O., MortonD.B., RowanA.N., RussellC., RussellW.M.S., SpielmannH., StephensM.L., StokesW.S., StraughanD.W., YagerJ.D., ZurloJ., & van ZutphenB.F.M. (1995). The Three Rs: the Way Forward. ECVAM Workshop Report 11. ATLA23, 838–866.
19.
RussellW.M.S., & BurchR.L. (1959). The Principles of Humane Experimental Technique.238 pp. London, UK: Methuen.
LiebschM., TraueD., BarrabasC., SpielmannH., UphillP., WilkinsS., WiemannC., KaufmannT., RemmeleM., & HolzhütterH.G. (2000). The ECVAM prevalidation study on the use of EpiDerm for skin corrosivity testing. ATLA28, 371–401.
22.
ECVAM (2000). Statement on the application of the EpiDerm™ human skin model for skin corrosivity testing. ATLA28, 365–366.
23.
OECD (2004). OECD Guideline for the Testing of Chemicals 431. In Vitro Skin Corrosion: Human Skin Model Test.8 pp. Paris, France: OECD.
24.
BothamP.A., ChamberlainM., BarrattM.D., CurrenR.D., EsdaileD.J., GardinerJ.R., GordonV.C., HildebrandB., LewisR.W., LiebschM., LogemannP., OsborneR., PonecM., RégnierJ-F., SteilingW., WalkerA.P., & BallsM. (1995). A prevalidation study on in vitro skin corrosivity testing. The report and recommendations of ECVAM workshop 6. ATLA23, 219–255.
25.
GerberickG.F., RyanC.A., KimberI., DearmanR.J., LeaL.J., & BasketterD.A. (2000). Local lymph node assay: validation assessment for regulatory purposes. The American Journal of Contact Dermatology11, 3–18.
WorthA.P., & BallsM., eds. (2002). Alternative (non-animal) methods for chemicals testing: current status and future prospects. A report prepared by ECVAM and the ECVAM Working Group on Chemicals. ATLA30, Suppl. 1, 1–125.
28.
CombesR., BarrattM., & BallsM. (2003). An overall strategy for the testing of chemicals for human hazard and risk assessment under the EU REACH system. ATLA31, 7–19.
29.
EU (2005). REACH and the Need for Intelligent Testing Strategies. EUR 21544 EN. 33 pp. Ispra, Italy: EC Joint Research Centre.
30.
EU (2003). Proposal for a Regulation of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency and amending Directive 1999/45/EC and Regulation (EC) {on Persistent Organic Pollutants}. Proposal for a Directive of the European Parliament and of the Council amending Council Directive 67/548/EEC in order to adapt it to Regulation (EC) of the European Parliament and of the Council concerning the registration, evaluation, authorisation and restriction of chemicals. COM 2003 0644 (03). 273 pp. Website http://europa.eu.int/eur-lex/en/com/pdf/2003/com2003_0644en.html (Accessed 05.01.06).
31.
HartungT., BremerS., CasatiS., CoeckeS., CorviR., FortanerS., GribaldoL., HalderM., Janusch-RoiA., PrietoP., SabbioniE., WorthA., & ZuangV. (2003). ECVAM's response to the changing political environment for alternatives: consequences of the European Union chemicals and cosmetics policies. ATLA31, 473–481.
32.
FentemJ., ChamberlainM., & SangsterB. (2004). The feasibility of replacing animal testing for assessing consumer safety: a suggested future direction. ATLA32, 617–623.
33.
BhogalN., GrindonC., CombesR., & BallsM. (2005). Toxicity testing: creating a revolution based on new technologies. Trends in Biotechnology23, 299–307.
34.
EskesC., & ZuangV., eds. (2005). Alternative (non-animal) methods for cosmetics testing: current status and future prospects. A report prepared in the context of the 7th Amendment of the Cosmetics Directive for establishing the timetable for phasing out animal testing. ATLA33, Suppl. 1, 1–228.
35.
BothamP.A. (2005). The ECVAM skin irritation validation study. ALTEX22, 151.
36.
OECD (2004). OECD Guideline for the Testing of Chemicals 428. Skin Absorption: In Vitro Method.15 pp. Paris, France: OECD.
37.
OECD (2004). OECD Guideline for the Testing of Chemicals 430. In Vitro Skin Corrosion: Trans-cutaneous Electrical Resistance Test (TER).11 pp. Paris, France: OECD.
38.
OECD (2004). OECD Guideline for the Testing of Chemicals 432. In Vitro 3T3 NRU Phototoxicity Test.10 pp. Paris, France: OECD.
39.
NC3Rs (2005). National Centre for the Replacement, Refinement and Reduction of Animals in Research. Website http://www.nc3rs.org.uk/ (Accessed 29.12.05).
40.
WestmorelandC., & FentemJ. (2004). Animal testing in the frame of new legislation. SoFW Journal (International Journal for Applied Science)130, 2–8.
41.
WalkerT.M., RhodesP.C., & WestmorelandC. (2000). The differential cytotoxicity of methotrexate in rat hepatocyte monolayer and spheroid cultures. Toxicology in Vitro14, 475–485.
42.
FletcherS.T., BakerV.A., FentemJ.H., BasketterD.A., & KelsellD.P. (2001). Gene expression analysis of EpiDerm™ following exposure to SLS using cDNA microarrays. Toxicology in Vitro15, 393–398.
43.
HarriesH.M., FletcherS.T., DugganC.M., & BakerV.A. (2001). The use of genomics technology to investigate gene expression changes in cultured human liver cells. Toxicology in Vitro15, 399–405.
44.
ShannonP., MarkielA., OzierO., BaligaN.S., WangJ.T., RamageD., AminN., SchwikowskiB., & IdekerT. (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research13, 2498–2504.
45.
AlbrechtM., HuthmacherC., TosattoS.C., & LengauerT. (2005). Decomposing protein networks into domain–domain interactions. Bioinformatics21, Suppl. 2, 220–221.
46.
PearsonR.G., BhandariR., QuirkR.A., & ShakesheffK.M. (2002). Recent advances in tissue engineering: an invited review. Journal of Long Term Effects of Medical Implants12, 1–33.
47.
MichelsonS. (2003). Assessing the impact of predictive biosimulation on drug discovery and development. Journal of Bioinformatics & Computational Biology1, 169–177.
48.
GrassG.M., & SinkoP.J. (2002). Physiologically-based pharmacokinetic simulation modelling. Advances in Drug Delivery Reviews54, 433–451.
